Skip to content

Requiem for UK R&D

Science minister David Willetts recently claimed that universities were responsible for picking up the slack in R&D following Pfizer’s run for the hills – in this writer’s opinion the first of many rats* to flee this sinking ship.

We need only cast our minds back a month or so to remember the government’s announcement that universities would be facing a 9.5% cut in funding in 2011-12, with a 4% cut in research funding. This makes the whole situation feel a lot like 1 step backwards and 2 steps back.

So what is the government trying to achieve?

Well, it’s a mystery to me. They claim their commitment to improving pharmaceutical research in the UK, yet the above points make this seem impossible. Add this to the push for value-based pricing and this really seems like the death of quality research in the UK.

Am I the only one with such fears?

*used only for metaphorical purposes – not pejorative!

By

  • Founder of the Academic Health Economists' Blog. Principal Economist at the Office of Health Economics. ORCID: 0000-0001-9470-2369

close

We now have a newsletter!

Sign up to receive updates about the blog and the wider health economics world.

0 0 votes
Article Rating
Subscribe
Notify of
guest

2 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
Chris Sampson
Chris Sampson
11 years ago

Giving with one hand and taking away with the other?
Government injects £775m into NHS translational research

eco-hack
Member
11 years ago

Just thinking back to this….. http://www.sciencedaily.com/releases/2008/01/080105140107.h
If Pharma’s spent a bit less on their marketing then this wouldn’t be necessary!

Also you will find this recently published article a fascinating read….again about how pharma’s are not doing us justice….
http://www.palgrave-journals.com/biosoc/journal/vaop/ncurrent/full/biosoc201040a.html

2
0
Would love your thoughts, please comment.x
()
x
%d bloggers like this: